Renal papillary necrosis classification: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Renal papillary necrosis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.<br> {{CMG}};...")
 
mNo edit summary
 
Line 7: Line 7:


==Overview==
==Overview==
[[Renal papillary necrosis]] is classified according to the severity of [[renal]] parenchymal lesions.
[[Renal papillary necrosis]] may be classified according to the severity of [[renal]] parenchymal lesions into two subtypes: [[Medullary]] and [[Papillary]].
 
==Classification==
==Classification==
* [[Renal papillary necrosis]] may be classified according to the severity of [[renal]] parenchymal lesions into two subtypes<ref name="pmid27251962">{{cite journal| author=Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K| title=Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria. | journal=Niger J Clin Pract | year= 2016 | volume= 19 | issue= 4 | pages= 471-4 | pmid=27251962 | doi=10.4103/1119-3077.183299 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27251962  }} </ref>:
* [[Renal papillary necrosis]] may be classified according to the severity of [[renal]] parenchymal lesions into two subtypes<ref name="pmid27251962">{{cite journal| author=Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K| title=Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria. | journal=Niger J Clin Pract | year= 2016 | volume= 19 | issue= 4 | pages= 471-4 | pmid=27251962 | doi=10.4103/1119-3077.183299 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27251962  }} </ref>:

Latest revision as of 07:52, 31 August 2020

Renal papillary necrosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Renal papillary necrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Renal papillary necrosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal papillary necrosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal papillary necrosis classification

CDC on Renal papillary necrosis classification

Renal papillary necrosis classification in the news

Blogs on Renal papillary necrosis classification

Directions to Hospitals Treating Renal papillary necrosis

Risk calculators and risk factors for Renal papillary necrosis classification

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]


Overview

Renal papillary necrosis may be classified according to the severity of renal parenchymal lesions into two subtypes: Medullary and Papillary.

Classification


Staging of Renal papillary necrosis

  • According to the histological finding of renal papillary necrosis, there are five grades based on the severity. "Renal Papillary Necrosis - an overview | ScienceDirect Topics".


References

  1. Madu AJ, Okoye AE, Ajuba IC, Madu KA, Anigbo C, Agu K (2016). "Prevalence and associations of symptomatic renal papillary necrosis in sickle cell anemia patients in South-Eastern Nigeria". Niger J Clin Pract. 19 (4): 471–4. doi:10.4103/1119-3077.183299. PMID 27251962.